Clinical trial
Tissue Acquisition for Analysis of Prognostic Factors, Immunology, and Genetic Progression of HIV-1 Associated Malignancies
NCT01567722 is registered in ClinicalTrials.gov with AIDS Malignancy Consortium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tissue Acquisition for Analysis of Prognostic Factors, Immunology, and Genetic Progression of HIV-1 Associated Malignancies
- Lead sponsor
- AIDS Malignancy Consortium
- Phase
- Observational
- Overall status
- Terminated
- Start date
- January 2, 2013
- Completion date
- January 14, 2022
- Enrollment
- 114 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer, lymphoma